$WVE news
The latest WVE stock news: headlines, filings, AI summaries and sentiment for $WVE, updated around the clock.
- Wave Life Sciences Reports Strong Q3 2026 Results with Robust Cash Position and Clinical Progress
- Wave Life Sciences Announces Post-Incretin Maintenance Trial Timeline and Extended Cash Runway
- Wave Life Sciences Reports Q3 2026 Financial Results and Clinical Pipeline Updates
- Wave Life Sciences, Inc. - 10-Q Filing
- Wave Life Sciences, Inc. - 8-K Filing
- Wave Life Sciences Reports Q3 Revenue Beat and Improved Earnings Per Share
- Wave Life Sciences to Receive $12M Milestone Payment from GSK
- Wave Life Sciences Reports Q2 2026 Financial Results and Clinical Progress
- Wave Life Sciences Ltd. - 10-Q Filing
- Wave Life Sciences Ltd. - 8-K Filing
- Wave Life Sciences Ltd. - 8-K Filing
- Exome Asset Management Exits $5.49 Million Stake in Wave Life Sciences Amid Q1 Struggles
- Exome Asset Management Exits $5.49 Million Stake in Wave Life Sciences Amid Rough First Quarter
- Wave Life Sciences Ltd. - 8-K Filing
- Wave (WVE) Reports Q1 2026 Earnings with Revenue Growth and Pipeline Advancements
- Wave (WVE) Reports Q1 2025 Earnings with Revenue Decline and Increased Expenses
- Wave (WVE) Reports Q2 2025 Earnings with Revenue Decline and Increased Expenses
- Wave Life Sciences Reports Q1 GAAP EPS of -$0.13, Revenue of $38.25M
- Wave Life Sciences Ltd. (WVE) Receives Strong Buy Rating from Analysts